Your browser is no longer supported. Please, upgrade your browser.
HZNP [NASD]
Horizon Therapeutics Public Limited Company
Index- P/E56.32 EPS (ttm)1.63 Insider Own0.90% Shs Outstand220.63M Perf Week9.73%
Market Cap20.52B Forward P/E17.57 EPS next Y5.23 Insider Trans-23.57% Shs Float217.89M Perf Month25.68%
Income389.80M PEG1.98 EPS next Q0.27 Inst Own92.20% Short Float3.00% Perf Quarter33.40%
Sales2.20B P/S9.32 EPS this Y-37.60% Inst Trans2.29% Short Ratio2.58 Perf Half Y25.34%
Book/sh18.25 P/B5.04 EPS next Y38.90% ROA7.50% Target Price113.00 Perf Year168.59%
Cash/sh9.32 P/C9.86 EPS next 5Y28.40% ROE12.60% 52W Range23.81 - 96.54 Perf YTD25.65%
Dividend- P/FCF53.18 EPS past 5Y48.20% ROI8.90% 52W High-4.80% Beta1.09
Dividend %- Quick Ratio3.40 Sales past 5Y23.80% Gross Margin75.80% 52W Low286.01% ATR4.36
Employees1395 Current Ratio3.50 Sales Q/Q105.00% Oper. Margin20.80% RSI (14)60.00 Volatility5.92% 4.78%
OptionableYes Debt/Eq0.00 EPS Q/Q-71.50% Profit Margin17.70% Rel Volume0.58 Prev Close90.91
ShortableYes LT Debt/Eq0.25 EarningsFeb 24 BMO Payout0.00% Avg Volume2.53M Price91.91
Recom1.70 SMA206.43% SMA5015.91% SMA20031.72% Volume1,474,104 Change1.10%
Sep-09-20Initiated JP Morgan Overweight $110
Aug-27-20Initiated Citigroup Buy $112
Jan-08-20Initiated Goldman Neutral $35
Sep-26-19Initiated BofA/Merrill Buy $34
Sep-12-19Initiated Guggenheim Buy
Aug-14-19Upgrade BMO Capital Markets Market Perform → Outperform $29 → $36
May-01-19Upgrade Citigroup Neutral → Buy $21 → $32
Mar-08-19Upgrade Morgan Stanley Equal-Weight → Overweight $32
Nov-15-18Downgrade Mizuho Buy → Neutral
Jun-27-18Downgrade Citigroup Buy → Neutral
Jan-12-18Upgrade Mizuho Neutral → Buy $12 → $18
Sep-28-17Initiated Goldman Buy $16
Jun-16-17Initiated Cantor Fitzgerald Overweight $13
May-09-17Reiterated Stifel Buy $35 → $20
May-09-17Downgrade Mizuho Buy → Neutral $22 → $10
Feb-28-17Reiterated Mizuho Buy $25 → $22
Dec-16-16Upgrade Mizuho Neutral → Buy $14 → $25
Dec-09-16Downgrade Mizuho Buy → Neutral $30 → $14
Nov-28-16Upgrade Citigroup Neutral → Buy
Nov-08-16Reiterated Mizuho Buy $29 → $30
Feb-26-21 04:05PM  
Feb-25-21 04:05PM  
03:27PM  
12:03PM  
Feb-24-21 04:41PM  
04:11PM  
11:01AM  
07:00AM  
Feb-22-21 09:30AM  
Feb-20-21 08:33PM  
Feb-18-21 01:08PM  
Feb-17-21 12:44PM  
Feb-10-21 01:40PM  
Feb-04-21 01:54PM  
Feb-03-21 12:53PM  
08:00AM  
Feb-02-21 07:40AM  
Feb-01-21 03:12PM  
02:57PM  
02:05PM  
09:36AM  
07:27AM  
07:00AM  
Jan-26-21 03:39PM  
01:42PM  
Jan-20-21 12:45PM  
Jan-18-21 08:46PM  
Jan-11-21 07:00AM  
Jan-08-21 02:23AM  
Jan-05-21 06:00AM  
Dec-22-20 08:00AM  
Dec-17-20 06:40AM  
Dec-15-20 04:13PM  
10:40AM  
Dec-14-20 01:58PM  
Dec-09-20 10:42AM  
Dec-07-20 01:57PM  
01:11PM  
10:56AM  
Dec-03-20 09:00AM  
Dec-02-20 09:15AM  
Dec-01-20 02:22AM  
Nov-30-20 08:00AM  
Nov-25-20 08:00AM  
Nov-23-20 08:00AM  
08:00AM  
Nov-18-20 10:11AM  
Nov-17-20 09:15AM  
Nov-16-20 10:54AM  
Nov-13-20 10:40AM  
10:31AM  
08:30AM  
08:00AM  
Nov-12-20 08:00AM  
Nov-03-20 12:50AM  
Nov-02-20 04:15PM  
02:00PM  
08:12AM  
07:00AM  
06:58AM  
Oct-30-20 09:15AM  
08:00AM  
Oct-29-20 03:17PM  
03:00PM  
02:25PM  
08:00AM  
Oct-26-20 10:04PM  
08:00AM  
07:29AM  
Oct-23-20 08:00AM  
Oct-22-20 10:00AM  
Oct-20-20 08:00AM  
Oct-16-20 11:05AM  
08:30AM  
Oct-14-20 08:00AM  
Oct-09-20 06:14PM  
Oct-08-20 08:15AM  
08:00AM  
Oct-07-20 08:00AM  
Oct-06-20 04:22PM  
Oct-05-20 07:45PM  
08:00AM  
Oct-01-20 04:00PM  
Sep-29-20 08:00AM  
Sep-23-20 04:14PM  
Sep-16-20 04:33PM  
12:19PM  
08:00AM  
Sep-15-20 11:37AM  
10:48AM  
Sep-14-20 05:34PM  
Sep-10-20 12:11PM  
Sep-08-20 10:24AM  
Sep-03-20 10:23AM  
Sep-02-20 09:00AM  
Sep-01-20 08:00AM  
Aug-28-20 04:29PM  
11:03AM  
Aug-27-20 09:56AM  
Aug-26-20 01:33PM  
Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. Its orphan and rheumatology marketed medicines include KRYSTEXXA, a medicine for the treatment of uncontrolled gout; RAVICTI for use as a nitrogen-binding agent for chronic management of adult and pediatric patients; PROCYSBI for nephropathic cystinosis, a rare and life-threatening metabolic disorder; ACTIMMUNE for chronic granulomatous disease; RAYOS for the treatment of rheumatoid arthritis (RA), polymyalgia rheumatic, systemic lupus erythematosus, and various other indications; BUPHENYL tablets for oral administration and BUPHENYL powder for oral, nasogastric, or gastrostomy tube administration; and QUINSAIR, a formulation of the antibiotic drug levofloxacin for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis. The company also offers PENNSAID 2% that is indicated for the treatment of pain of osteoarthritis (OA) of the knees; DUEXIS for the relief of signs and symptoms of RA and OA, and to decrease the risk of developing upper-GI ulcers; and VIMOVO for the relief of signs and symptoms of OA, RA, and ankylosing spondylitis to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. It has collaboration agreements with Lupus Research and HemoShear Therapeutics, LLC. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DesJardin Michael A.EVP, Technical OperationsFeb 26Sale91.831,099100,92186,247Feb 26 06:12 PM
DesJardin Michael A.EVP, Technical OperationsFeb 24Sale92.4815,9441,474,44887,346Feb 26 06:12 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffFeb 22Sale87.225,698496,98781,677Feb 23 06:19 PM
Karnani VikramEVP & President, InternationalFeb 22Sale87.198,358728,722104,165Feb 23 06:20 PM
DesJardin Michael A.EVP, Technical OperationsFeb 11Sale90.0010,786970,740101,200Feb 12 05:01 PM
DesJardin Michael A.EVP, Technical OperationsFeb 02Sale85.004,530385,050111,986Feb 04 05:39 PM
Walbert Timothy PChairman, President and CEOFeb 01Option Exercise0.009,087022,895Feb 03 05:24 PM
Karnani VikramEVP & President, InternationalJan 22Sale76.812,731209,768111,429Jan 22 09:05 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffJan 22Sale76.812,226170,97986,500Jan 22 09:04 PM
Walbert Timothy PChairman, President and CEOJan 22Sale76.4711,323865,917946,559Jan 22 08:59 PM
Camardo Daniel A.EVP and President, U.S.Jan 21Option Exercise0.003,220046,503Jan 22 09:09 PM
Beeler Brian KEVP, General CounselJan 21Option Exercise0.004,1200123,472Jan 22 09:08 PM
McHugh Miles WSr VP & Princ. Acctg OfficerJan 21Option Exercise0.003,590035,206Jan 22 09:08 PM
DesJardin Michael A.EVP, Technical OperationsJan 21Option Exercise0.003,6780118,340Jan 22 09:06 PM
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOJan 21Option Exercise0.003,760087,205Jan 22 09:07 PM
Karnani VikramEVP & President, InternationalJan 21Option Exercise0.004,9040116,333Jan 22 09:05 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffJan 21Option Exercise0.003,999090,498Jan 22 09:04 PM
MOZE BARRYEVP, Chief Admin. OfficerJan 21Option Exercise0.005,8190172,762Jan 22 09:03 PM
Kent JeffSee remarksJan 21Option Exercise0.003,045071,468Jan 22 09:02 PM
Hoelscher Paul W.EVP, CFOJan 21Option Exercise0.005,55606,605Jan 22 09:01 PM
Walbert Timothy PChairman, President and CEOJan 21Option Exercise0.002,575014,563Jan 22 08:59 PM
Walbert Timothy PChairman, President and CEOJan 21Option Exercise0.0020,3300966,889Jan 22 08:59 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerJan 21Option Exercise0.005,353081,361Jan 22 09:00 PM
Walbert Timothy PChairman, President and CEOJan 15Sale77.89211,20416,449,893946,559Jan 15 05:43 PM
DesJardin Michael A.EVP, Technical OperationsJan 06Option Exercise16.3527,106443,296141,768Jan 08 05:32 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffJan 06Sale74.7626,8442,006,85486,499Jan 08 05:33 PM
Karnani VikramEVP & President, InternationalJan 06Sale75.0030,0312,252,325111,429Jan 08 05:31 PM
DesJardin Michael A.EVP, Technical OperationsJan 06Sale75.0027,1062,032,950114,662Jan 08 05:32 PM
McHugh Miles WSr VP & Princ. Acctg OfficerDec 14Sale80.001,856148,48019,741Dec 15 05:00 PM
DesJardin Michael A.EVP, Technical OperationsDec 10Sale69.645,909411,50363,392Dec 11 04:41 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerDec 08Sale71.1540,7642,900,354174,955Dec 09 05:05 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerDec 07Sale70.9463,0784,474,860215,719Dec 09 05:05 PM
McHugh Miles WSr VP & Princ. Acctg OfficerNov 12Sale75.4812,124915,12021,597Nov 13 07:27 PM
Camardo Daniel A.EVP and President, U.S.Nov 06Sale76.763,500268,66330,829Nov 06 06:00 PM
Kent JeffSee remarksNov 05Sale78.9447,9443,784,66351,049Nov 06 06:00 PM
MOZE BARRYEVP, Chief Admin. OfficerNov 05Sale78.9377,5006,117,259100,709Nov 06 06:00 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerOct 21Option Exercise7.6113,00098,93028,015Oct 21 05:06 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffSep 17Option Exercise14.0521,351299,98257,373Sep 18 05:00 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffSep 16Sale78.888,919703,53136,022Sep 18 05:00 PM
Beeler Brian KEVP, General CounselSep 04Option Exercise14.9128,143419,66664,028Sep 08 04:51 PM
Hoelscher Paul W.EVP, CFOAug 24Sale75.7629,5762,240,702102,925Aug 25 05:16 PM
Walbert Timothy PChairman, President and CEOAug 06Sale72.54110,0007,979,414733,792Aug 07 05:42 PM
GREY MICHAEL GDirectorAug 05Option Exercise3.951,7556,9321,755Aug 07 05:40 PM
GREY MICHAEL GDirectorAug 05Sale73.351,755128,7290Aug 07 05:40 PM
Karnani VikramEVP & President, InternationalAug 03Option Exercise13.1536,772483,63678,941Aug 05 01:24 PM
SANTINI GINODirectorAug 03Option Exercise2.8835,795103,26235,795Aug 04 04:56 PM
GREY MICHAEL GDirectorJul 22Option Exercise3.951,7556,9321,755Jul 22 05:33 PM
GREY MICHAEL GDirectorJul 22Sale60.001,755105,3000Jul 22 05:33 PM
Kent JeffSee remarksJul 07Option Exercise5.6838,000215,98098,993Jul 07 06:57 PM
MOZE BARRYEVP, Chief Admin. OfficerJul 07Option Exercise13.1735,076461,918178,209Jul 07 06:50 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerJul 06Sale57.509,100523,250278,797Jul 07 06:49 PM
MOZE BARRYEVP, Chief Admin. OfficerJul 01Sale54.6423,1581,265,441143,133Jul 02 04:46 PM
GREY MICHAEL GDirectorJun 25Option Exercise3.951,7556,9321,755Jun 26 05:00 PM
GREY MICHAEL GDirectorJun 25Sale55.001,75596,5250Jun 26 05:00 PM
Kent JeffSee remarksJun 10Sale48.052,785133,81960,993Jun 12 06:00 PM
Kent JeffSee remarksJun 01Sale49.9457,2152,857,17960,994Jun 02 06:18 PM
Karnani VikramEVP, Chief Commercial OfficerJun 01Sale50.232,369118,99542,169Jun 02 06:17 PM
Beeler Brian KEVP, General CounselJun 01Sale50.232,370119,04535,885Jun 02 06:16 PM
CURTIS GEOFFREY M.EVP, Corporate Affairs, CCOMay 26Sale49.8521,9181,092,61234,834May 27 05:00 PM
GREY MICHAEL GDirectorMay 22Option Exercise7.8410,53082,55510,530May 26 05:00 PM
GREY MICHAEL GDirectorMay 22Sale48.7710,530513,5050May 26 05:00 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerMay 11Option Exercise4.9633,479166,05647,445May 12 04:12 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerMay 11Sale45.0033,4791,506,55513,966May 12 04:12 PM
McHugh Miles WSr VP & Princ. Acctg OfficerMay 11Sale44.2249,1142,171,58530,816May 12 04:11 PM
McHugh Miles WSr VP & Princ. Acctg OfficerMay 08Sale43.5145,3661,973,71179,930May 12 04:11 PM
DesJardin Michael A.EVP, Technical OperationsMay 07Option Exercise14.9323,159345,76464,359May 07 04:29 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffMay 06Option Exercise14.0559,794840,10695,183May 07 04:31 PM
Beeler Brian KEVP, General CounselMay 06Sale40.8048,0001,958,51537,206May 07 04:32 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffMay 06Sale41.1959,7942,462,91535,389May 07 04:31 PM
McHugh Miles WSr VP & Princ. Acctg OfficerMay 06Sale41.193,545146,019129,095May 07 04:30 PM
DesJardin Michael A.EVP, Technical OperationsMay 06Sale41.5917,959747,00441,200May 07 04:29 PM
McHugh Miles WSr VP & Princ. Acctg OfficerMay 05Sale37.005,007185,259132,640May 07 04:30 PM
DesJardin Michael A.EVP, Technical OperationsMay 05Sale38.008,980341,24059,159May 07 04:29 PM
Hoelscher Paul W.EVP, CFOMay 05Sale38.00104,9943,989,772132,501May 07 04:27 PM
Beeler Brian KEVP, General CounselApr 29Sale35.0215,880556,11885,206Apr 30 05:50 PM
Karnani VikramEVP, Chief Commercial OfficerApr 29Sale35.0015,683548,90543,489Apr 30 05:49 PM
Karnani VikramEVP, Chief Commercial OfficerApr 28Sale35.0130,0631,052,50659,172Apr 30 05:49 PM
Konstantinovsky IrinaEVP, Chief Human Resources OffApr 20Sale34.1319,886678,68535,389Apr 21 05:00 PM
Beeler Brian KEVP, General CounselApr 16Sale32.519,000292,615101,086Apr 17 04:23 PM
Beeler Brian KEVP, General CounselApr 07Sale32.502979,653110,086Apr 08 04:46 PM
Beeler Brian KEVP, General CounselApr 06Sale32.502,37077,025110,383Apr 08 04:46 PM
MOZE BARRYEVP, Chief Admin. OfficerMar 30Option Exercise12.942,10627,252168,397Mar 31 05:01 PM
MOZE BARRYEVP, Chief Admin. OfficerMar 30Sale28.182,10659,347166,291Mar 31 05:01 PM
SHERMAN JEFFREY WEVP and Chief Medical OfficerMar 11Option Exercise12.945,28768,41413,966Mar 13 04:15 PM